rufinamide has been researched along with cannabidiol in 5 studies
| Studies (rufinamide) | Trials (rufinamide) | Recent Studies (post-2010) (rufinamide) | Studies (cannabidiol) | Trials (cannabidiol) | Recent Studies (post-2010) (cannabidiol) |
|---|---|---|---|---|---|
| 175 | 22 | 118 | 3,279 | 321 | 2,646 |
| Protein | Taxonomy | rufinamide (IC50) | cannabidiol (IC50) |
|---|---|---|---|
| Cholinesterase | Equus caballus (horse) | 0.67 | |
| Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | 0.75 | |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 0.45 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 3.7 | |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 2.8 | |
| Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | 5.9 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bebin, EM; Cutter, GR; Gaston, TE; Liu, Y; Szaflarski, JP | 1 |
| Auvin, S | 1 |
| Brigo, F; Eltze, C; Jones, K; Matricardi, S | 1 |
| García-Peñas, JJ; Gil Nagel-Rein, A; Sánchez-Carpintero, R; Villanueva-Haba, V | 1 |
| Wang, C; Wang, J; Zhang, L | 1 |
4 review(s) available for rufinamide and cannabidiol
| Article | Year |
|---|---|
Lennox-Gastaut syndrome: New treatments and treatments under investigation.
Topics: Anticonvulsants; Cannabidiol; Drug Development; Drugs, Investigational; Fenfluramine; Humans; Lennox Gastaut Syndrome; Nitriles; Pyridones; Therapies, Investigational; Triazoles | 2020 |
Anti-seizure medications for Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Cinnamates; Clobazam; Electroencephalography; Felbamate; Humans; Lamotrigine; Lennox Gastaut Syndrome; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Topiramate; Triazoles; Wakefulness; Young Adult | 2021 |
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Clonazepam; Diazepam; Dioxolanes; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Phenobarbital; Practice Guidelines as Topic; Pyrrolidinones; Spain; Triazoles; Valproic Acid | 2021 |
Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Cannabidiol; Child; Humans; Lennox Gastaut Syndrome; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Triazoles | 2022 |
1 other study(ies) available for rufinamide and cannabidiol
| Article | Year |
|---|---|
Interactions between cannabidiol and commonly used antiepileptic drugs.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Benzodiazepines; Cannabidiol; Child; Child, Preschool; Clobazam; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Fructose; Humans; Male; Middle Aged; Topiramate; Triazoles; Young Adult | 2017 |